SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00003293
First received: November 1, 1999
Last updated: September 10, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2001
  Primary Completion Date: May 2001 (Final data collection date for primary outcome measure)